Does POCT reduce the risk of error in laboratory testing?

被引:70
作者
Plebani, Mario [1 ]
机构
[1] Univ Hosp Padova, Dept Lab Med, I-35128 Padua, Italy
关键词
Point-of-care testing; Errors; Patient safety; Total testing process; Latent condition for error; Turn-around time; INTENSIVE-CARE-UNIT; PATIENT SAFETY; GLUCOSE METERS; BLOOD-GAS; POINT; PERFORMANCE; VALIDATION; BIOMARKERS; LIABILITY; CLINICIAN;
D O I
10.1016/j.cca.2009.03.014
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Point-of-care testing (POCT), the fastest growing segment of the current clinical laboratory testing market, is a rapid means for providing test results in different clinical settings. In theory, this tool eliminates some of the more problematic steps in the testing process. including specimen transport and result distribution. However, POCT has created new challenges. and sources of potential errors: moreover, while the upsurge in its use has generated concerns regarding the quality of test results, few data are available in the literature oil errors with POCT. Nor are data available for the evaluation of errors, and the risk of errors in POCT based on all steps in the entire testing process, including test requesting and result utilization. According to a modified Kost model, which takes into account all steps of the testing process and latent conditions for error. POCT reduces errors and the risk of error in only a few steps of the testing process. There is therefore ail urgent need for an evaluation of errors and risks of error in POCT that is based on the entire testing process and uses well-designed studies aiming to improve clinical outcomes and increase patient safety. (c) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:59 / 64
页数:6
相关论文
共 67 条
[1]   ENTEROBACTER-CLOACAE IN A NEONATAL INTENSIVE-CARE UNIT - ACCOUNT OF AN OUTBREAK AND ITS RELATIONSHIP TO USE OF 3RD-GENERATION CEPHALOSPORINS [J].
ACOLET, D ;
AHMET, Z ;
HOUANG, E ;
HURLEY, R ;
KAUFMANN, ME .
JOURNAL OF HOSPITAL INFECTION, 1994, 28 (04) :273-286
[2]  
[Anonymous], 223672008 ISOTS
[3]   The pharmacology and management of the vitamin K antagonists [J].
Ansell, J ;
Hirsh, J ;
Poller, L ;
Bussey, H ;
Jacobson, A ;
Hylek, E .
CHEST, 2004, 126 (03) :204S-233S
[4]  
Bonini P, 2002, CLIN CHEM, V48, P691
[5]   Errors in a stat laboratory: Types and frequencies 10 years later [J].
Carraro, Paolo ;
Plebani, Mario .
CLINICAL CHEMISTRY, 2007, 53 (07) :1338-1342
[6]   Post-analytical errors with portable glucose meters in the hospital setting [J].
Carraro, Paolo ;
Plebani, Mario .
CLINICA CHIMICA ACTA, 2009, 404 (01) :65-67
[7]   Management of diabetes and is hyperglycemia in hospitals [J].
Clement, S ;
Braithwaite, SS ;
Magee, MF ;
Ahmann, A ;
Smith, EP ;
Schafer, RG ;
Hirsh, IB .
DIABETES CARE, 2004, 27 (02) :553-591
[8]  
CREYSON J, 1993, DIABETES CARE, V16, P1306
[9]  
DEMERS LM, 1999, POINT CARE TESTING, P102
[10]   Medicolegal liability in laboratory medicine [J].
Dighe, Anand S. ;
Makar, Robert S. ;
Lewandrowski, Kent B. .
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2007, 24 (02) :98-107